Cited by 69interferon and immune responsesImmune Response and InflammationHIV Research and Treatment

Adrenergic inhibition of innate anti-viral response: PKA blockade of Type I interferon gene transcription mediates catecholamine support for HIV-1 replication

Collado-Hidalgo, Alicia, Sung, Caroline, Cole, Steve·2006·Brain, Behavior, and Immunity

Abstract

Type I interferons (IFN-alpha and -beta) play a key role in anti-viral immunity, and we sought to define the molecular mechanisms by which the sympathetic nervous system (SNS) inhibits their effects. In peripheral blood leukocytes and plasmacytoid dendritic cells (pDC2), induction of interferon anti-viral activity by double-stranded RNA (poly-I:C) or CpG DNA was substantially inhibited by norepinephrine and by pharmacologic activation of the cAMP/PKA signaling pathway. This effect was specific to Type I interferons and driven by PKA-mediated repression of IFNA and IFNB gene transcription. Luciferase reporter analyses identified tandem interferon response factor-binding sites in positive regulatory domains I and III of the IFNB promoter as a key target of PKA inhibition. PKA suppression of Type I interferons was associated with impaired transcription of interferon response genes supporting the "anti-viral state", and was sufficient to account for norepinephrine-induced enhancement of HIV-1 replication. Given the ubiquitous role of Type I interferons in containing viral replication, PKA-mediated inhibition of IFN transcription could explain the stimulatory effects of catecholamines on a broad range of viral pathogens.

Integrity signals

Registry

Crossref · 10.1016/j.bbi.2006.01.005

Cites

114 of 114 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • SNS activation of the CTRA is mediated in large part by beta-adrenergic receptors, which stimulate transcription factors such as NF-kB, GATA, and CREB to up-regulate proinflammatory genes while inhibiting interferon response factor family transcription factors that control Type I interferon genes.

    “SNS activation of the CTRA is mediated in large part by β-adrenergic receptors, which stimulate transcription factors such as nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), GATA, and cAMP response element-binding protein (CREB) to selectively up-regulate transcription of proinflammatory genes (e.g., IL6 [19]) while simultaneously inhibiting the activity of transcription”

    From Human Social Genomics (2014) · cites this paper as [34]

  • The sympathetic nervous system allows the CNS to steer innate immune responses between proinflammatory and antiviral phenotypes.

    “the SNS allows the CNS to 'steer' innate immune responses between proinflammatory and antiviral phenotypes”

    From Sleep health: Reciprocal regulation of sleep and innate immunity (2017) · cites this paper as Collado-Hidalgo et al, 2006

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Collado-Hidalgo, A., Sung, C., & Cole, S.
Affiliations
University of California, Los Angeles (US)
Corresponding author
Cole, Steve
Venue
Brain, Behavior, and Immunity
Publisher
Elsevier BV
Published
2006-11
Volume
20
Issue
6
Pages
552-563
ISSN
0889-1591 (ISSN-L)
OpenAlex
W2084120087
Cited by
69
References
114
Citations by year
2026: 2 · 2025: 3 · 2023: 4 · 2022: 2 · 2021: 7 · 2020: 3 · 2019: 3 · 2018: 1 · 2017: 1 · 2016: 4 · 2015: 3 · 2014: 4 · 2013: 7 · 2012: 4
FWCI
1.77
Type
journal article
Language
en
Open access
closed
Locations
  • Brain Behavior and Immunity (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institute of Mental Health (T32MH019925, T32 MH 19925)
  • National Institute of Allergy and Infectious Diseases (R01 AI52737, R01AI052737)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
Keywords
type I interferon, protein kinase A, sympathetic nervous system, norepinephrine, catecholamines, HIV-1 replication, antiviral innate immunity, plasmacytoid dendritic cells, interferon-beta promoter, cAMP signaling, double-stranded RNA, CpG DNA
MeSH terms
Autonomic Nervous System, Cells, Cultured, Dendritic Cells, Gene Expression Regulation, Humans, Immunity, Innate, Interferon Type I, Leukocytes, Norepinephrine, Promoter Regions, Genetic, RNA, Double-Stranded, Transcription, Genetic, Virus Replication, Neuroimmunomodulation, Signal Transduction, HIV-1, HIV Infections, Cyclic AMP-Dependent Protein Kinases, CpG Islands

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review